Sirignano, P.; Mangialardi, N.; Nespola, M.; Aloisi, F.; Orrico, M.; Ronchey, S.; Del Porto, F.; Taurino, M.
Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers. J. Pers. Med. 2022, 12, 339.
https://doi.org/10.3390/jpm12030339
AMA Style
Sirignano P, Mangialardi N, Nespola M, Aloisi F, Orrico M, Ronchey S, Del Porto F, Taurino M.
Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers. Journal of Personalized Medicine. 2022; 12(3):339.
https://doi.org/10.3390/jpm12030339
Chicago/Turabian Style
Sirignano, Pasqualino, Nicola Mangialardi, Martina Nespola, Francesco Aloisi, Matteo Orrico, Sonia Ronchey, Flavia Del Porto, and Maurizio Taurino.
2022. "Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers" Journal of Personalized Medicine 12, no. 3: 339.
https://doi.org/10.3390/jpm12030339
APA Style
Sirignano, P., Mangialardi, N., Nespola, M., Aloisi, F., Orrico, M., Ronchey, S., Del Porto, F., & Taurino, M.
(2022). Incidence and Fate of Refractory Type II Endoleak after EVAR: A Retrospective Experience of Two High-Volume Italian Centers. Journal of Personalized Medicine, 12(3), 339.
https://doi.org/10.3390/jpm12030339
